cabozantinib,nivolumab
exelixis,bms
['9er', 'renal,(-adrenal)', 'magnitude']
a post hoc analysis of #chekmate9er data, conducted by and presented at #asco, confirms there is a correlation between the magnitude of treatment response and better results in patients with renal cancer. 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre